Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. - Wikidata - awgldk - TriplyDB

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

http://www.wikidata.org/entity/Q46415313

about

Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization Proteins and small molecules for cellular regenerative medicine Hematopoietic stem cell niche maintenance during homeostasis and regeneration Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.Diabetes impairs hematopoietic stem cell mobilization by altering niche function.Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.Plerixafor European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial Economic evaluation of plerixafor for stem cell mobilization.Successful mobilization, intra-apheresis recruitment, and harvest of hematopoietic progenitor cells by addition of plerixafor and subsequent large-volume leukapheresis.Plerixafor in the treatment of stem cell mobilization failure; first experience in iran.Stem cell mobilization in HIV seropositive patients with lymphoma.Improving stem cell mobilization strategies: future directions.Optimal time to start peripheral blood stem cell collection in children with high-risk solid tumors.The role of natalizumab in hematopoietic stem cell mobilization.Advances in mobilization for the optimization of autologous stem cell transplantation.Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution.Peripheral blood stem cell mobilization tactics.Plerixafor for stem cell mobilization in patients with non-Hodgkin's lymphoma and multiple myeloma.Plerixafor: a peripheral blood stem cell mobilizer.Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens.Novel strategies for blood stem cell mobilization: special focus on plerixafor.How we mobilize haemopoietic stem cells.Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma.Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.Development of novel CXCR4-based therapeutics.The evolving role of plerixafor in hematopoietic progenitor cell mobilization.

P2860

Q26825518-2B98C319-C8AA-4E3C-9277-757310E7CA30 Q26850495-B70BFA77-1A61-4123-9156-BCD1ABF97B8F Q26865273-28633ABD-534D-46C3-88D2-631FC7D0D1FA Q27692619-1446B951-D48E-4F39-A961-57E28427A5BE Q30543776-BBEBD072-7013-4289-9115-B0BE14F0FD3B Q30962747-5B55ECF8-A16E-4FED-B732-266551C7DFF3 Q33543723-5DC6B3BB-EA06-4C5F-9E7D-74A3F66B92A5 Q33885517-EFCB265B-08AA-42F6-88C3-35A58CDA054F Q34073741-044EC257-4FDD-43CA-972D-50FFE1D65941 Q34114055-40B9D377-15F6-4DCE-BBC9-A370680CBB56 Q34454624-CCD445D4-DC23-415F-846F-4D03654E9307 Q34490998-09A0FA4E-AF98-4838-B52A-80E1E65A7C54 Q34762492-7B117362-E1FA-47A2-8DCF-BFAFCF6D4956 Q35049174-77ACB0E0-6575-4F70-8BA5-0AB8A7B29634 Q35881779-E402F015-4581-4BB8-AD3D-70761A3BFB9E Q35911212-C55CC7C0-62AF-4D7F-92BD-DB1F4CAB0F7B Q35994520-C990B1FB-9CDE-481F-80BD-C199898DCFEA Q36121171-43AA67DB-DF72-4233-BC72-F4B46991D196 Q36445393-5CB503C2-FBEF-455B-9FE2-53D154BE3F5A Q36579055-2DC3A2DB-0B01-4BD2-BB94-1C5828CFCA75 Q36831799-E19A6B7A-8BAC-4FB3-AB2F-00377D7260CC Q37180930-93AE7964-CDB3-4603-8A54-02295CF1CB4D Q37268725-DBDDE31E-1984-4562-BCDC-A7D14B82A014 Q37273199-BCBC005F-8216-46BA-B472-A4C2E5241342 Q37367235-09322BD1-BA6D-4231-A1A7-A7EC1D1A56EC Q37473582-57458099-AE22-4776-B508-EA4903B099D4 Q37536053-B82D1DE7-8D92-4A51-AF21-9702FFEA1095 Q37551715-34A1CE24-3911-405C-95D1-282954133BD8 Q37605108-9ED638B7-FC41-4C12-AEB0-B2EBA494B0B9 Q37641380-EB1872D6-C7B7-4116-A438-096DF18B1500 Q37649251-F83DF747-FF77-4C82-B710-AB96C92A8F8B Q37653639-E46D1FD6-8DCA-4F00-9CFB-DA5966CFF62D Q37735840-3D12E338-20CF-4C0E-951A-CE134932C07B Q37827058-8128F67F-4FE9-4B82-83E1-12ABA44EB345 Q37909447-720D9C47-A439-4ABC-B045-9BFB6D37480F Q37914921-3F8AB889-779D-4C9A-9313-86D5CF89500C Q37921284-161B1ECC-2005-4C15-A752-CC93B80FD073 Q37943423-26EB4C86-08B1-465C-B86D-1045A11CE06D Q37979306-46DBBE2A-A93D-41B4-88BF-AD6D55AA63F7 Q38077807-B270E106-7E3C-4C25-A43D-58EE90752798

P2860

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

http://www.wikidata.org/entity/Q46415313

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Impact of mobilization and rem ...... or autologous transplantation.

@en

Impact of mobilization and rem ...... or autologous transplantation.

@nl

type

label

Impact of mobilization and rem ...... or autologous transplantation.

@en

Impact of mobilization and rem ...... or autologous transplantation.

@nl

prefLabel

Impact of mobilization and rem ...... or autologous transplantation.

@en

Impact of mobilization and rem ...... or autologous transplantation.

@nl

P1433

Q46415313-0081C587-1408-43D1-9D5E-B0C9CB27E3FD

P1476

Q46415313-730EFAA8-F878-4D6A-9506-FF1E1160CAFB

P2093

Q46415313-2CB77DD9-F8BE-4E6E-BFD9-491180CE02BE

Q46415313-3B110D4A-1834-45AC-B1B0-844408C5D092

Q46415313-6B6051EA-9D0E-436C-829B-4124EF6D360C

Q46415313-9A08DE2D-DC13-45D3-BE3F-BC2201957709

Q46415313-AFED8060-C0F1-4F7F-A3A1-B3AA4CBB9D32

Q46415313-BDFE547D-B6D1-45BF-B709-295A0EC8CF5C

Q46415313-C2D9423B-BBFE-4FF7-8E88-661120B5FB17

Q46415313-CC59E561-486C-4625-8E67-0B8AE3E06C90

Q46415313-DA51B8BB-F29B-475A-B69D-B115AAC76777

Q46415313-E30CCC0C-8A95-4480-B556-26E8212CE9B3

P304

Q46415313-44040EF8-F7C7-43CC-9003-A943198A43E1

P31

Q46415313-6681EDED-509C-4ADD-9AE8-7CD9F5D189D8

P356

Q46415313-A09D7DA0-7894-4E2B-8410-16E568F7EF52

P433

Q46415313-924F30CE-AE7F-4BB1-832B-A95933D58490

P478

Q46415313-CC6B275C-7DB4-43DE-88C1-349807ADF3B3

P50

Q46415313-B0287468-517A-4982-BE14-E05F7804AACF

P577

Q46415313-FF97E58F-78E6-4CC8-ADBA-041C2832B318

P698

Q46415313-9864B708-2EC1-4B91-BF9A-DC3018472410

P356

J.BBMT.2008.07.004

P1433

Biology of Blood and Marrow Transplantation

P1476

Impact of mobilization and rem ...... for autologous transplantation

@en

P2093

Amanda F Cashen

http://www.w3.org/2001/XMLSchema#string

Angela L Smith

http://www.w3.org/2001/XMLSchema#string

Camille N Abboud

http://www.w3.org/2001/XMLSchema#string

Diane S Sempek

http://www.w3.org/2001/XMLSchema#string

Iskra Pusic

http://www.w3.org/2001/XMLSchema#string

John F DiPersio

http://www.w3.org/2001/XMLSchema#string

Keith E Stockerl-Goldstein

http://www.w3.org/2001/XMLSchema#string

Michael P Rettig

http://www.w3.org/2001/XMLSchema#string

Peter Westervelt

http://www.w3.org/2001/XMLSchema#string

Ravi Vij

http://www.w3.org/2001/XMLSchema#string

P304

1045-1056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2008.07.004

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18721768

http://www.w3.org/2001/XMLSchema#string